B Voller

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
    B Voller
    Department of Clinical Pharmacology, University of Vienna, Austria
    Neurology 61:940-4. 2003
  2. ncbi request reprint Safety study of high-frequency transcranial magnetic stimulation in patients with chronic stroke
    M P Lomarev
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, NIH Building 10, Room 5N240, 10 Center Dr MSC 1428, Bethesda, MD 20892 1428, USA
    Clin Neurophysiol 118:2072-5. 2007
  3. ncbi request reprint Neuropsychological, MRI and EEG findings after very mild traumatic brain injury
    B Voller
    Department of Neurology, University of Vienna, Wien, Austria
    Brain Inj 13:821-7. 1999
  4. ncbi request reprint Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region
    B Voller
    Department of Neurology, University of Vienna, Austria
    Neurology 56:107-9. 2001
  5. ncbi request reprint Cortical control of voluntary blinking: a transcranial magnetic stimulation study
    Y H Sohn
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bldg 10 Room 5N226, 10 Center Drive, Bethesda, MD 20892 1428, USA
    Clin Neurophysiol 115:341-7. 2004
  6. ncbi request reprint The impact of blepharospasm and cervical dystonia on health-related quality of life and depression
    J Muller
    Department of Neurology, Innsbruck University Hospital, Anichstr 35, Austria
    J Neurol 249:842-6. 2002
  7. pmc Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument
    J Muller
    University Hospital of Neurology, Innsbruck, Austria University Hospital of Psychiatry, Innsbruck, Austria
    J Neurol Neurosurg Psychiatry 75:749-53. 2004
  8. ncbi request reprint An open study of botulinum-A toxin treatment of trigeminal neuralgia
    B Voller
    Neurology 66:1458-9; author reply 1458-9. 2006
  9. doi request reprint Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A
    G Kranz
    Department of Neurology, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Neurology 70:133-6. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
    B Voller
    Department of Clinical Pharmacology, University of Vienna, Austria
    Neurology 61:940-4. 2003
    ..Botulinum toxin type A (BTXA) is used to treat neurologic disorders associated with increased muscle tone. Its use is often associated with pain relief...
  2. ncbi request reprint Safety study of high-frequency transcranial magnetic stimulation in patients with chronic stroke
    M P Lomarev
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, NIH Building 10, Room 5N240, 10 Center Dr MSC 1428, Bethesda, MD 20892 1428, USA
    Clin Neurophysiol 118:2072-5. 2007
    ..Repetitive transcranial magnetic stimulation (rTMS) is a potential therapeutic tool to rehabilitate chronic stroke patients. In this study, the safety of high-frequency rTMS in stroke was investigated (Phase I)...
  3. ncbi request reprint Neuropsychological, MRI and EEG findings after very mild traumatic brain injury
    B Voller
    Department of Neurology, University of Vienna, Wien, Austria
    Brain Inj 13:821-7. 1999
    ..In the EEG recordings, no generalized slowing or focal changes were found. Structural and functional impairment can be identified using neuroimaging and neuropsychological examination, even in very MTBI patients...
  4. ncbi request reprint Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region
    B Voller
    Department of Neurology, University of Vienna, Austria
    Neurology 56:107-9. 2001
    ..The patient improved after suboccipital craniotomy, C1 to C6 laminectomy, and removal of the thickened dura. Additional therapy with methotrexate stopped progression, which was documented by MRI and PET...
  5. ncbi request reprint Cortical control of voluntary blinking: a transcranial magnetic stimulation study
    Y H Sohn
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bldg 10 Room 5N226, 10 Center Drive, Bethesda, MD 20892 1428, USA
    Clin Neurophysiol 115:341-7. 2004
    ..To investigate cortical regions related to voluntary blinking...
  6. ncbi request reprint The impact of blepharospasm and cervical dystonia on health-related quality of life and depression
    J Muller
    Department of Neurology, Innsbruck University Hospital, Anichstr 35, Austria
    J Neurol 249:842-6. 2002
    ....
  7. pmc Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument
    J Muller
    University Hospital of Neurology, Innsbruck, Austria University Hospital of Psychiatry, Innsbruck, Austria
    J Neurol Neurosurg Psychiatry 75:749-53. 2004
    ..To develop and test a questionnaire for measuring quality of life in patients with craniocervical dystonia...
  8. ncbi request reprint An open study of botulinum-A toxin treatment of trigeminal neuralgia
    B Voller
    Neurology 66:1458-9; author reply 1458-9. 2006
  9. doi request reprint Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A
    G Kranz
    Department of Neurology, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Neurology 70:133-6. 2008
    ..We tested whether neutralizing BoNT/A-ABs can be detected in dystonic patients with good clinical responses to botulinum toxin A (BoNT/A) treatment...